How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the value of HealthVerity real-world data in evaluating HIV prevention strategies. 1 Published in Clinical Infectious Diseases, the study relied on HealthV...